| 前收盘价格 | 9.11 |
| 收盘价格 | 9.17 |
| 成交量 | 3,946,367 |
| 平均成交量 (3个月) | 5,892,674 |
| 市值 | 1,478,507,392 |
| 预期市盈率 (P/E Forward) | 8.14 |
| 价格/销量 (P/S) | 1.46 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -32.18% |
| 营业利益率 (TTM) | -153.61% |
| 稀释每股收益 (EPS TTM) | -2.18 |
| 季度收入增长率 (YOY) | -54.80% |
| 季度盈利增长率 (YOY) | 179.90% |
| 流动比率 (MRQ) | 0.940 |
| 营业现金流 (OCF TTM) | -90.88 M |
| 杠杆自由现金流 (LFCF TTM) | -247.39 M |
| 资产报酬率 (ROA TTM) | -10.76% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Novavax, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.13 |
|
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.40% |
| 机构持股比例 | 60.31% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (B. Riley Securities, 181.69%) | 购买 |
| 中 | 25.00 (170.86%) | |
| 低 | 19.00 (HC Wainwright & Co., 105.85%) | 购买 |
| 平均值 | 23.33 (152.76%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 10.61 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 10 Dec 2024 | 19.00 (105.85%) | 购买 | 8.77 |
| 13 Nov 2024 | 19.00 (105.85%) | 购买 | 7.77 | |
| Jefferies | 16 Oct 2024 | 25.00 (170.86%) | 购买 | 10.15 |
| 02 Oct 2024 | 31.00 (235.86%) | 购买 | 14.68 | |
| B. Riley Securities | 10 Oct 2024 | 26.00 (181.69%) | 购买 | 12.91 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合